Suppr超能文献

sigma 受体与可卡因滥用。

Sigma receptors and cocaine abuse.

机构信息

Department of Medicinal Chemistry, School of Pharmacy, The University of Mississippi, University, 38677, USA.

出版信息

Curr Top Med Chem. 2011;11(9):1128-50. doi: 10.2174/156802611795371323.

Abstract

Sigma receptors have been well documented as a protein target for cocaine and have been shown to be involved in the toxic and stimulant actions of cocaine. Strategies to reduce the access of cocaine to sigma receptors have included antisense oligonucleotides to the sigma-1 receptor protein as well as small molecule ligand with affinity for sigma receptor sites. These results have been encouraging as novel protein targets that can attenuate the actions of cocaine are desperately needed as there are currently no medications approved for treatment of cocaine toxicity or addiction. Many years of research in this area have yet to produce an effective treatment and much focus was on dopamine systems. A flurry of research has been carried out to elucidate the role of sigma receptors in the blockade of cocaine effects but this research has yet to yield a clinical agent. This review summarizes the work to date on the linkage of sigma receptors and the actions of cocaine and the progress that has been made with regard to small molecules. Although there is still a lack of an agent in clinical trials with a sigma receptor mechanism of action, work is progressing and the ligands are becoming more selective for sigma systems and the potential remains high.

摘要

西格玛受体已被充分证实为可卡因的蛋白靶点,并已被证明参与可卡因的毒性和兴奋作用。减少可卡因与西格玛受体结合的策略包括针对西格玛-1 受体蛋白的反义寡核苷酸以及对西格玛受体具有亲和力的小分子配体。这些结果令人鼓舞,因为目前急需新型蛋白靶点来减轻可卡因的作用,而没有批准用于治疗可卡因毒性或成瘾的药物。在该领域进行了多年的研究,但仍未产生有效的治疗方法,并且很多研究重点都放在多巴胺系统上。大量研究已经开展,以阐明西格玛受体在阻断可卡因作用中的作用,但这项研究尚未产生临床药物。这篇综述总结了目前关于西格玛受体与可卡因作用的联系的研究进展,以及在小分子方面取得的进展。尽管在具有西格玛受体作用机制的临床试验中仍缺乏药物,但研究正在进行,配体对西格玛系统的选择性越来越高,潜力仍然很高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验